| Code | 3764A | ||||||||||
| MA number | 14/0479/11-S | ||||||||||
| Product Form: | gra 98x4 mg (vre.ílov.sulf./LDPE/Al/surlyn) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 14 - BRONCHODILATANTIA, ANTIASTHMATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | sachet clay sulf./LDPE/ Al/surlyn | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 09.08.2011 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Montelukast Teva gra_03/2024.pdf
|
| SPC: |
SPC_Montelukast Teva_gra_03/2024.pdf
|
| Safety feature | Yes |
| Data update: | 07.11.2018 |
